Skip to Main Content

Author Details

Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
1992
403
65
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37776287Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients.Int J Cancer2024
37945316Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.Br J Haematol2024
37776287Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients.Int J Cancer2024
37945316Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.Br J Haematol2024
34196794Results from a pilot study on the oral microbiome in children and adolescents with chronic nonbacterial osteomyelitis.Z Rheumatol2023
35484663B-cell precursor leukemias with <i>MYC</i>-rearrangement come into the limelight.Haematologica2023
36332176EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy.Blood2023
35537032Noncancer-related Secondary Findings in a Cohort of 231 Children With Cancer and Their Parents.J Pediatr Hematol Oncol2023
37670804AP-1 Transcription Factor Complex Members <i>FOSB</i> and <i>FOS</i> are Linked With CNS Infiltration and Inferior Prognosis in Childhood T-ALL.Hemasphere2023
37582744Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumors.Mol Cancer2023
37717691High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.Biochem Pharmacol2023
38057328Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells.Cell Death Dis2023
37158619Temporal patterns of childhood cancer survival 1991 to 2016: A nationwide register-study based on data from the German Childhood Cancer Registry.Int J Cancer2023
37469802Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood <i>ETV6::RUNX1+</i> and High Hyperdiploid Acute Lymphoblastic Leukemia.Hemasphere2023
37033933Arenaviruses: Old viruses present new solutions for cancer therapy.Front Immunol2023
37149759A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children.Genet Med2023
36824296Resolving inherited and <i>de novo</i> germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies.Front Pediatr2023
36647327Reply to: Comments on "The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients".Int J Cancer2023
36764385Functional damaging germline variants in ETV6, IKZF1, PAX5 and RUNX1 predisposing to B-cell precursor acute lymphoblastic leukemia.Eur J Med Genet2023
36639636Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group.J Exp Clin Cancer Res2023
36639156Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.J Immunother Cancer2023
37448856Development of the first geldanamycin-based HSP90 degraders.Front Chem2023
37439330Worms on stage.Haematologica2023
36741356Cytokine Hyperresponsiveness in Children With ETV6::RUNX1-positive Acute Lymphoblastic Leukemia After Challenge With Common Pathogens.Hemasphere2023
37304931Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia.Hemasphere2023
36468172The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients.Int J Cancer2023
37046711Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials.Cancers (Basel)2023
34196794Results from a pilot study on the oral microbiome in children and adolescents with chronic nonbacterial osteomyelitis.Z Rheumatol2023
37670804AP-1 Transcription Factor Complex Members <i>FOSB</i> and <i>FOS</i> are Linked With CNS Infiltration and Inferior Prognosis in Childhood T-ALL.Hemasphere2023
37717691High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.Biochem Pharmacol2023
37582744Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumors.Mol Cancer2023
38057328Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells.Cell Death Dis2023
35537032Noncancer-related Secondary Findings in a Cohort of 231 Children With Cancer and Their Parents.J Pediatr Hematol Oncol2023
35484663B-cell precursor leukemias with <i>MYC</i>-rearrangement come into the limelight.Haematologica2023
37158619Temporal patterns of childhood cancer survival 1991 to 2016: A nationwide register-study based on data from the German Childhood Cancer Registry.Int J Cancer2023
37149759A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children.Genet Med2023
37046711Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials.Cancers (Basel)2023
37448856Development of the first geldanamycin-based HSP90 degraders.Front Chem2023
37469802Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood <i>ETV6::RUNX1+</i> and High Hyperdiploid Acute Lymphoblastic Leukemia.Hemasphere2023
37439330Worms on stage.Haematologica2023
37304931Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia.Hemasphere2023
37033933Arenaviruses: Old viruses present new solutions for cancer therapy.Front Immunol2023
36647327Reply to: Comments on "The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients".Int J Cancer2023
36741356Cytokine Hyperresponsiveness in Children With ETV6::RUNX1-positive Acute Lymphoblastic Leukemia After Challenge With Common Pathogens.Hemasphere2023
36468172The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients.Int J Cancer2023
36639636Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group.J Exp Clin Cancer Res2023
36639156Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.J Immunother Cancer2023
36764385Functional damaging germline variants in ETV6, IKZF1, PAX5 and RUNX1 predisposing to B-cell precursor acute lymphoblastic leukemia.Eur J Med Genet2023
36824296Resolving inherited and <i>de novo</i> germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies.Front Pediatr2023
36332176EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy.Blood2023
  • 1 - 50 of 806

Recommended Authors

Thai Hoa Tran
Universite de Montreal
Career Start Year 2013
Number of shared co-authors 4
Pascal St-Onge
CHU Sainte-Justine Research Center
Career Start Year 2007
Number of shared co-authors 5
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 1
Yana Pikman
Dana Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 4
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 7
Christopher C Porter
Emory University School of Medicine
Career Start Year 2003
Number of shared co-authors 6
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 10
Guang Fan
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 1
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 0
David M Weinstock
Merck & Co.
Career Start Year 1998
Number of shared co-authors 10
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 1
Gordana Raca
Children's Hospital Los Angeles
Career Start Year 1997
Number of shared co-authors 6
Yongjin Li
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 13
Lucy A Godley
The University of Chicago
Career Start Year 1994
Number of shared co-authors 10
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 12
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 15
Bill H Chang
Oregon Health and Science University
Career Start Year 1993
Number of shared co-authors 3
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Julie M Gastier-Foster
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 11
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Career Start Year 1991
Number of shared co-authors 77
Mary Shago
The Hospital for Sick Children, University of Toronto
Career Start Year 1990
Number of shared co-authors 10
Stephen P Hunger
Children's Hospital of Philadelphia
Career Start Year 1990
Number of shared co-authors 16
Geoffrey Neale
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 35
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year 1989
Number of shared co-authors 8
Shifra Ash
Ruth Rappaport Children's Hospital
Career Start Year 1988
Number of shared co-authors 3
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Daniel Sinnett
Sainte-Justine University Hospital Research Center
Career Start Year 1986
Number of shared co-authors 11
Kim E Nichols
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 40
Ching-Hon Pui
St. Jude Children's Research Hospital
Career Start Year 1980
Number of shared co-authors 13
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 16

Collaborators

Ute Fischer
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers 54
Michaela Kuhlen
Co-authored papers 50
Michael Gombert
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Co-authored papers 32
Thomas Klingebiel
Co-authored papers 19
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 17
Daniel Picard
Groupe Hospitalier Universitaire Pitie-Salpetriere
Co-authored papers 17
Markus Metzler
University Hospital Erlangen
Co-authored papers 16
Birgit Burkhardt
Co-authored papers 16
Cornelia Eckert
Co-authored papers 14
Guido Reifenberger
Heinrich Heine University
Co-authored papers 12
Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Co-authored papers 11
Alice C McHardy
Computational Biology of Infection Research, Helmholtz Centre for Infection Research
Co-authored papers 11
Reiner Siebert
Co-authored papers 11
Ewa Koscielniak
Co-authored papers 9
Uta Dirksen
University Hospital Essen, West German Cancer Center
Co-authored papers 9
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 9
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 9
Nan Qin
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 9
Jasmin Bartl
German Cancer Research Center (DKFZ)
Co-authored papers 8
Andreas E Kulozik
Co-authored papers 8
Matthias Schlesner
University of Augsburg
Co-authored papers 7
Angelika Eggert
Co-authored papers 7
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers 7
Rainer M Bohle
Co-authored papers 7
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 7
Charlotte M Niemeyer
Co-authored papers 7
Frauke-Dorothee Meyer
German Cancer Research Center (DKFZ)
Co-authored papers 7
Pablo Landgraf
Co-authored papers 7
Stefan Burdach
Technische Universitat Munchen
Co-authored papers 7
Chris Lawerenz
German Cancer Research Center (DKFZ)
Co-authored papers 7
Release 1.2